(IJJ) S&P Mid-Cap 400 Value - Overview
Etf: Mid-Cap, Value, Equities, Diversified
Dividends
| Dividend Yield | 1.86% |
| Yield on Cost 5y | 2.75% |
| Yield CAGR 5y | 7.12% |
| Payout Consistency | 97.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.1% |
| Relative Tail Risk | -4.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | -1.82 |
| Character TTM | |
|---|---|
| Beta | 0.921 |
| Beta Downside | 0.956 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.68% |
| CAGR/Max DD | 0.49 |
Description: IJJ S&P Mid-Cap 400 Value January 06, 2026
The iShares S&P Mid-Cap 400 Value ETF (NYSE ARCA: IJJ) tracks an index that reflects the performance of U.S. mid-cap stocks classified as “value.” The fund is required to hold at least 80 % of its assets in the index’s component securities-or securities that are economically equivalent-and may allocate up to the remaining 20 % to futures, options, swaps, cash, or cash equivalents.
Key data points (as of the latest reporting period): - **Assets under management (AUM):** roughly $9 billion, placing it among the larger mid-cap value ETFs. - **Weighted average market cap:** about $12 billion, confirming its mid-cap focus. - **Top sector exposures:** Financials (~30 %), Industrials (~25 %), and Consumer Staples (~15 %), sectors that tend to benefit from a flattening yield curve and moderate inflation. - **Economic drivers:** The fund’s performance is sensitive to interest-rate differentials (which affect financials) and to corporate earnings growth in the mid-cap space, which historically outpaces large-cap growth during early-to-mid-cycle expansions.
If you want a deeper, data-driven view of how IJJ fits into a value-oriented portfolio, ValueRay’s analytical tools can help you assess risk-adjusted returns and sector tilt in real time.
What is the price of IJJ shares?
Over the past week, the price has changed by +5.02%, over one month by +5.34%, over three months by +14.00% and over the past year by +13.10%.
Is IJJ a buy, sell or hold?
What are the forecasts/targets for the IJJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 159.9 | 11.3% |
IJJ Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 8.35b USD (8.35b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 8.35b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 8.35b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.31% (E(8.35b)/V(8.35b) * Re(9.31%) + (debt-free company))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)